Health Canada recommends people with rare blood condition not get AstraZeneca vaccine

Health Canada is updating the product monograph-or label-for the AstraZeneca and Covishield COVID-19 vaccines to add capillary leak syndrome as a potential side effect

Health Canada said yesterday it has recommended that people with a history of capillary leak syndrome not be vaccinated with drugmaker AstraZeneca’s COVID-19 vaccine.

“Health Canada is updating the product monograph-or label-for the AstraZeneca and Covishield COVID-19 vaccines to add capillary leak syndrome as a potential side effect, with a warning for patients with a history of capillary leak syndrome to not get the AstraZeneca or Covishield COVID-19 vaccine”, it said in a statement.